Sakamaki H | Hematology Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
スポンサーリンク
概要
- SAKAMAKI Hisashiの詳細を見る
- 同名の論文著者
- Hematology Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospitalの論文著者
関連著者
-
SUGIYAMA Haruo
Departments of Clinical Laboratory Science
-
AKIYAMA Hideki
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
SAKAMAKI Hisashi
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
OHASHI Kazuteru
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
坂本 弘明
Department of Internal Medicine II, Fukushima Medical University, School of Medicine
-
斉藤 広信
福島県立医科大学 医学部内科学第二講座
-
三木 義男
癌研ゲノムセンター
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Seto M
Department Of Hematology And Chemotherapy
-
TAWARA Masayuki
Nagasaki CML Study Group
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
Sao Hiroshi
Department of Hematology, Meitetsu Hospital
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
Miyamoto Toshihiro
Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
Seto Masao
愛知県がんセンター研究所 分子腫瘍学部
-
TESHIMA Takanori
Center for Cellular and Molecular Medicine, Kyushu University Hospital
-
NAGAFUJI Koji
Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences
-
Kato T
Department Of Gastroenterological Surgery Aichi Cancer Center Hospital
-
OHNO Ryuzo
Aichi Cancer Center
-
SAKAMAKI Hisashi
Division of Hematology, Tokyo Metropolitan Komagome Hospital
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
MORI Shin-ichiro
Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital
-
SAKAMAKI Hisashi
Department of Hematology, Tokyo Metropolitan Komagome Hospital
-
MARUTA Atsuo
Department of Hematology, Kanagawa Cancer Center
-
高橋 厚史
九州大学
-
Tobinai Kensei
東海大学 医学部
-
高橋 厚史
九州大学大学院工学研究院航空宇宙工学部門
-
高橋 厚史
九州大学工学部
-
KODERA Yoshihisa
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
Kami Masahiro
Jr東京総合病院 血液内科
-
KANDA Yoshinobu
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo
-
Harada Mine
Department Of Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
Harada M
Department Of Hematology-oncology Ehime Prefectural Central Hospital
-
KAKIHANA Kazuhiko
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
MIYAZAKI Yasushi
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
Iida Hiroatsu
Department of Hematology, Meitetsu Hospital
-
谷脇 雅文
高知工科大学工学部
-
MORI Shinichiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
TOMONAGA Masao
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
KOHNO Akio
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
OJI Yusuke
Departments of Clinical Laboratory Science
-
TSUBOI Akihiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
OKA Yoshihiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kami Masahiro
Division Of Exploratory Research Institute Of Medical Science University Of Tokyo
-
HATA Tomoko
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
JINNAI Itsuro
Nagasaki CML Study Group
-
KURIYAMA Kazutaka
Nagasaki CML Study Group
-
OKAMOTO Shinichiro
Division of Hematology, Department of Medicine, Keio University School of Medicine
-
MORI Takehiko
Division of Hematology, Department of Medicine, Keio University School of Medicine
-
Harada Mine
岡山大学 第2内科
-
YAMAGUCHI Toshikazu
Development of Clinical Genomics, BML
-
IMANISHI Daisuke
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
YAGASAKI Fumiharu
Department of Hematology, Saitama Medical University Hospital
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
OHTAKE Shigeki
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
永井 正
自治医科大学内科学講座血液学部門
-
ANDO KOJI
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University
-
吉川 秀樹
大阪大学大学院医学系研究科器官制御外科学(整形外科)
-
MIYAMURA Koichi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
TSUKASAKI Kunihiro
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
MATSUO Yuzi
the Department of Laboratory Midicine
-
MORISHITA Yoshihisa
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
吉川 秀樹
大阪大学大学院医学系研究科器官制御外科学
-
Soma T
Department Of Medicine National Hospital Organization Osaka Minami Medical Center
-
Soma Toshihiro
大阪大学 医学系研究科
-
Soma Toshihiro
Medicine Iii Osaka University Medical School
-
KAWAKAMI Manabu
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
KAWASE Ichiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
OGAWA Hiroyasu
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
HOSEN Naoki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
NISHIDA Sumiyuki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
SUZUKI Ritsuro
Department of HSCT Data Management, Nagoya University Hospital
-
永井 正
自治医科大学 内科学講座血液学部門
-
岡田 昌也
兵庫医科大学総合内科学血液・腫瘍科
-
Miura S
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Seto M
Aichi Cancer Center Res. Inst. Nagoya
-
Ogawa Daisuke
Nagasaki Cml Study Group
-
SAKAI Mari
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
MATSUO Emi
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
MORIUCHI Yukiyoshi
Nagasaki CML Study Group
-
FUKUSHIMA Takuya
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
IMAIZUMI Yoshitaka
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
TAGUCHI Jun
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
IWANAGA Masako
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
TSUSHIMA Hideki
Nagasaki CML Study Group
-
INOUE Yoriko
Nagasaki CML Study Group
-
TAKASAKI Yumi
Nagasaki CML Study Group
-
NAGAI Kazuhiro
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
TSUTSUMI Chizuko
Nagasaki CML Study Group
-
SAWAYAMA Yasushi
Nagasaki CML Study Group
-
YAMASAKI Reishi
Nagasaki CML Study Group
-
KAWAGUCHI Yasuhisa
Nagasaki CML Study Group
-
IKEDA Shuichi
Nagasaki CML Study Group
-
YOSHIDA Shinichiro
Nagasaki CML Study Group
-
ONIMARU Yasuyuki
Nagasaki CML Study Group
-
ATOGAMI Sunao
Nagasaki CML Study Group
-
JOH Tatsuro
Nagasaki CML Study Group
-
YAMAMURA Masaomi
Nagasaki CML Study Group
-
MATSUO Yuji
Nagasaki CML Study Group
-
SODA Hisashi
Nagasaki CML Study Group
-
NONAKA Hiroaki
Nagasaki CML Study Group
-
KANAMORI Heiwa
Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of
-
HIDAKA Michihiro
Department of Internal Medicine, Kumamoto Medical Center, National Hospital Organization
-
YOSHIDA Takashi
Hematology Department, Toyama Prefectural Hospital
-
Shimoda Kazuya
九州大学 医学部病態情報学
-
Honda Sumihisa
Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences
-
YAMAMOTO Masahide
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
TADOKORO Kenichi
Development of Clinical Genomics, BML
-
UEDA Ryuzo
Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sci
-
MIYAWAKI Shuichi
Division of Hematology, Saiseikai Maebashi Hospital
-
OKUMURA Hirokazu
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
MATSUDA Shin
Center for Hematopoietic Disorders, Ohta Nishinouchi Hospital, The Ohta Foundation
-
KISHIMOTO Yuji
The First Department of Internal Medicine, Kansai Medical University
-
TAKAHASHI Masatomo
Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School
-
ASOU Norio
Department of Hematology, Kumamoto University School of Medicine
-
UIKE Naokuni
Department of Hematology, National Kyushu Cancer Center
-
EMI Nobuhiko
Department of Hematology, Fujita Health University
-
MITANI Kinuko
Department of Hematology, Dokkyo University School of Medicine
-
MIYAZAKI Yasushi
The Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University School of Medicine
-
OGAWA Yoshiaki
Department of Hematology and Oncology, Tokai University School of Medicine
-
Kunitomi Akane
Department of Hematology, Meitetsu Hospital
-
Kamiya Yoshikazu
Department of Hematology, Meitetsu Hospital
-
清水 隆之
慶應義塾大学医学部血液内科
-
Miyazawa Keisuke
Department of Biochemistry and Intractable Immune System Disease Research Center, Tokyo Medical Univ
-
SANAKA Masaki
Department of Internal Medicine, Teikyo University School of Medicine
-
Mori Yasuo
Department of Synthetic Chemistry and Biological Chemistry, Kyoto University Graduate School of Engi
-
YOSHIKAWA Hideki
Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine
-
NAKAO Shinji
Department of Cellular Transplantation Biology, Graduate School of Medical Sciences, Kanazawa Univer
-
TAKAMI Akiyoshi
Department of Cellular Transplantation Biology, Kanazawa University Graduate School of Medicine
-
KAMI Masahiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
HOTTA Tomomitsu
Department of Hematology and Oncology, Tokai University School of Medicine
-
TSUCHIDA Masahiro
Department of Pediatrics, Ibaraki Children's Hospital
-
OGAWA Daisuke
Department of Medicine and Clinical Science (Internal Medicine III), Okayama University Graduate Sch
-
Takeuchi Kengo
Department Of Pathology Cancer Institute Japanese Foundation For Cancer Research
-
FUJIWARA TOHRU
Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine
-
OHASHI Haruhiko
Clinical Research Center for Blood Disease, National Hospital Organization Nagoya Medical Center
-
KAWA Keisei
Department of Hematology/Oncology, Osaka Medical Center and Research Institute for Maternal and Chil
-
YOSHIDA Takashi
Department of Pharmacognosy, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Oka
-
Yokoyama Reiko
Pharmacy Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
NISHIWAKI Satoshi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
TERAKURA Seitaro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
YASUDA Takahiko
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
IMAHASHI Nobuhiko
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
NIIMI Keiko
Department of Hematology, Meitetsu Hospital
-
YOKOZAWA Toshiya
Clinical Research Center, National Hospital Organization Nagoya Medical Center
-
SAWA Masashi
Department of Hematology, Anjo Kosei Hospital
-
NAJIMA Yuho
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
KAWAMURA Machiko
Pediatrics Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
ONOZUKA Yuji
Development of Clinical Genomics
-
IKEGAME Kazuhiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
OHNISHI Kazunori
Department of Internal Medicine, Hamamatsu University School of Medicine
-
SHIMOYAMA Masanori
National Cancer Center Hospital
-
NAKAGOME KAZUYUKI
Department of Psychiatry, Showa University School of Medicine
-
SHIMAO Yoshiya
Department of Pathology, Miyazaki Prefectural Hospital
-
SETO Masao
Laboratories of Chemotherapy and Immunology, Aichi Cancer Research Institute
-
Ueda R
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
USUI Noriko
Department of Medicine, Division of Hematology and Oncology, Jikei University School of Medicine
-
KOJIMA Hiroshi
Department of Hematology, Institute of Clinical Medicine, University of Tsukuba
-
MATSUO Keitaro
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute
-
HAMAJIMA Nobuyuki
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute
-
TANIGUCHI Shuichi
Department of Hematology, Toranomon Hospital
-
MORI Shin-ichiro
Department of Hematology, Tokyo Metropolitan Komagome Hospital
-
Naka Yoshifumi
大阪市立大学 医学研究科整形外科学
-
TSUCHIYA Takeshi
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
KOMODA Minori
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
HORIO Kensuke
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
MORIWAKI Yuji
Nagasaki CML Study Group
-
TOMINAGA Shinya
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
ITONAGA Hidehiro
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
KOIDA Satoshi
Nagasaki CML Study Group
-
ATSUTA Yoshiko
Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University
-
NAGAFUJI Koji
Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science
-
YOSHIBA Fumiaki
Department of Hematology and Oncology, Tokai University School of Medicine
-
ICHINOHE Tatsuo
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University
-
KASAI Masanobu
Department of Hematology, Nagoya Daini Red Cross Hospital
-
TAKATSUKA Yoshifusa
Department of Hematology, Imamura Bun-in Hospital
-
KUBO Kohmei
Department of Hematology, Aomori Prefectural Central Hospital
-
HARADA Mine
Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science
-
TANIWAKI Masafumi
Department of Environmental Systems Engineering, Kochi University of Technology
-
KOBAYASHI Takeshi
Department of Electrical Engineering, Faculty of Engineering Science, Osaka University
-
KAMEZAKI Kenjiro
Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences
-
INOUE Yasushi
Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu Universi
-
TSUKAMOTO Hiroshi
Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu Universi
-
HORIUCHI Takahiko
Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu Universi
-
Tsuda Hiroyuki
Division Of Clinical Hematology Kumamoto City Hospital
-
TAKAHASHI Naoto
Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine
-
SAWADA Kenichi
Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine
-
Shimoda K
Department Of Internal Medicine Gastroenterology And Hematology Faculty Of Medicine Miyazaki Univers
-
Tomonari Akira
東京大学医科学研究所附属病院 血液腫瘍内科
-
Tomonari Akira
Department Of Hematology/oncology The Institute Of Medical Science The University Of Tokyo
-
Tomonari Akira
Department Of Hematology/oncology
-
Horiuchi Takahiko
札幌医科大学 医学部
著作論文
- Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Use of Octreotide in the Management of Severe Duodenal Bleeding after Unrelated-Donor Bone Marrow Transplantation
- Primary Sclerosing Cholangitis Complicated with Idiopathic Thrombocytopenic Purpura
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Therapy-Related Leukemia and Myelodysplastic Syndrome: A Large-scale Japanese Study of Clinical and Cytogenetic Features as Well as Prognostic Factors
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
- High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
- Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation
- Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
- Mikulicz's disease with severe thrombocytopenia following autologous stem cell transplantation in a multiple myeloma patient
- Acquired Storage-Pool Disorders Occurring Late After Allogeneic Bone Marrow Transplantation: Partial Activation of Platelets in Asymptomatic Patients
- Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
- Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
- A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
- Successful treatment of refractory advanced nasal NK/T cell lymphoma with unrelated cord blood stem cell transplantation incorporating focal irradiation
- Second unrelated cord blood transplantation using a reduced-intensity conditioning regimen combined with gemtuzumab ozogamicin in patients with relapsed acute myelogenous leukemia
- Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
- Quality of Life in Adult Patients After Stem Cell Transplantation
- Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease
- Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion
- Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation
- Frequent Exacerbation of Pulmonary Nocardiosis during Maintenance Antibiotic Therapies in a Hematopoietic Stem Cell Transplant Recipient
- Immune-Mediated Myelopathy following Allogeneic Stem Cell Transplantation
- Pneumatosis coli after Thalidomide Treatment
- Granulocyte Colony-Stimulating Factor-Primed Donor Lymphocyte Infusion after Salvage Chemotherapy for Treatment of Relapsed Acute Leukemia after Allogeneic Stem Cell Transplantation
- Cytogenetic Abnormalities without Evidence of Relapse after Treatment with Imatinib and Stem Cell Transplantation in a Patient with Ph-Positive ALL
- Low-Dose Cyclosporin A with Short-Term Methotrexate for Graft-versus-Host Disease Prophylaxis in Allogeneic Bone Marrow Transplantation from Human Leukocyte Antigen-Identical Siblings : A Prospective Phase II Study in Japanese Patients
- Bone marrow transplantation in subjects with mental disorders
- Psychological factors and survival after bone marrow transplantation in patients with leukemia
- Hepatitis B Virus Reactivation in a Patient With Chronic GVHD After Allogeneic Peripheral Blood Stem Cell Transplantation
- Imatinib Mesylate (Gleevec) in the Treatment of 2 Patients with Philadelphia-Positive ALL Relapsing after Allogeneic Stem Cell Transplantation
- Successful Unrelated Bone Marrow Transplantation After Arsenic Trioxide Treatment in a Patient With Relapsed Acute Promyelocytic Leukemia
- Wegener's granulomatosis detected initially by integrated 18F-fluorodeoxyglucose positron emission tomography/computed tomography
- Erythrocytosis caused by erythropoietin-producing thymic carcinoma
- Low-Dose Antithymocyte Globulin for Treatment of Steroid-Pulse-Resistant Acute Graft-versus-Host Disease
- Effect of Additional Chromosomal Abnormalities in Acute Promyelocytic Leukemia Treated With All-trans-Retinoic Acid: A Report of 17 Patients
- Second Allogeneic Peripheral Blood Stem Cell Transplantation With Fludarabine-Based Low-Intensity Conditioning Regimen for Relapsed Myelodysplastic Syndrome After Allogeneic Bone Marrow Transplantation
- Unrelated Bone Marrow Transplantation Induced Long-Term Remission in a Patient with Life-Threatening Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Clinical Features and Outcomes of 35 Disseminated Intravascular Coagulation Cases Treated with Recombinant Human Soluble Thrombomodulin at a Single Institution
- Advances in therapies for acute promyelocytic leukemia
- Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation
- Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients